Rex Bionics PLC Directors Interests (9706K)
September 27 2016 - 8:00AM
UK Regulatory
TIDMRXB
RNS Number : 9706K
Rex Bionics PLC
27 September 2016
Rex Bionics plc
("Rex Bionics" or the "Company")
Directors Interests
27 September 2016 Rex Bionics plc (AIM: RXB), the pioneer of the
REX Robot technology that enhances the mobility of wheelchair
users, announces that pursuant to the existing Deferred Bonus Share
Plan (under which employees are issued options to subscribe for
cash at par for Ordinary Shares in respect of the bonus to which
they were otherwise entitled) the Company has made awards, for the
financial year ended 31 March 2016, in respect of an aggregate of
791,279 Ordinary Shares of 10p each in the Company ("Ordinary
Shares") (representing 3.1% of the current issued Ordinary Shares)
to certain employees in the Company including the Chief Executive
Officer, the Chief Financial Officer and the Chief Technology
Officer.
The Awards to those Directors are as follows:
Name Deferred Bonus Award
Shares
Crispin Simon
Chief Executive
Officer 140,000
Peter Worrall
Chief Financial
Officer 93,333
Richard Little
Chief Technology
Officer 134,070
For further information please contact:
Rex Bionics Plc
Peter Worrall, Chief Financial Officer
+44 (0) 142 864 5416
Stifel Securities Limited (NOMAD and Broker)
Jonathan Senior, Stewart Wallace, Ben Maddison
+44 (0) 20 7710 7600
Consilium Strategic Communications
Lindsey Neville
rexbionics@consilium-comms.com
+44 (0) 203 709 5700
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
----- ----------------------------------------------------------
(a) Name: CRISPIN SIMON
----- ----------------------------------------------------------
2. Reason for the notification
----- ----------------------------------------------------------
(a) Position/status: CHIEF EXECUTIVE
----- ----------------------------------------------------------
(b) Initial notification/Amendment: INITIAL
----- ----------------------------------------------------------
3. Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
----- ----------------------------------------------------------
(a) Name: REX BIONICS plc
----- ----------------------------------------------------------
(b) LEI: NA
----- ----------------------------------------------------------
4. Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
----- ----------------------------------------------------------
(a) Description of the Financial instrument, type
of instrument: Rex Bionics Option over Ordinary
Shares of 10p each
Identification code: ISIN: GB00BLRLQM66
----- ----------------------------------------------------------
(b) Nature of the transaction: Issue of awards
under Deferred Bonus Share Plan
----- ----------------------------------------------------------
(c) Price(s) and volume(s)
Price(s): 10p per Ordinary Share
Volume(s): 140,000
----- ----------------------------------------------------------
(d) Aggregated information
* Aggregated volume: 140,000 Ordinary Shares awarded
* Price: Exercise price: 10p per Ordinary Share
----- ----------------------------------------------------------
(e) Date of the transaction: 27 September 2016
----- ----------------------------------------------------------
(f) Place of the transaction: London Stock Exchange
- AIM
----- ----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
----- ---------------------------------------------------------
(a) Name: PETER WORRALL
----- ---------------------------------------------------------
2. Reason for the notification
----- ---------------------------------------------------------
(a) Position/status: CHIEF FINANCIAL OFFICER
----- ---------------------------------------------------------
(b) Initial notification/Amendment: INITIAL
----- ---------------------------------------------------------
3. Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
----- ---------------------------------------------------------
(a) Name: REX BIONICS plc
----- ---------------------------------------------------------
(b) LEI: NA
----- ---------------------------------------------------------
4. Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
----- ---------------------------------------------------------
(a) Description of the Financial instrument, type
of instrument: Rex Bionics Option over Ordinary
Shares of 10p each
Identification code: ISIN: GB00BLRLQM66
----- ---------------------------------------------------------
(b) Nature of the transaction: Issue of awards
under Deferred Bonus Share Plan
----- ---------------------------------------------------------
(c) Price(s) and volume(s)
Price(s): 10p per Ordinary Share
Volume(s): 93,333
----- ---------------------------------------------------------
(d) Aggregated information
* Aggregated volume: 93,333 Ordinary Shares awarded
* Price: Exercise price: 10p per Ordinary Share
----- ---------------------------------------------------------
(e) Date of the transaction: 27 September 2016
----- ---------------------------------------------------------
(f) Place of the transaction: London Stock Exchange
- AIM
----- ---------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
----- ----------------------------------------------------------
(a) Name: RICHARD LITTLE
----- ----------------------------------------------------------
2. Reason for the notification
----- ----------------------------------------------------------
(a) Position/status: CHIEF TECHNOLOGY OFFICER
----- ----------------------------------------------------------
(b) Initial notification/Amendment: INITIAL
----- ----------------------------------------------------------
3. Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
----- ----------------------------------------------------------
(a) Name: REX BIONICS plc
----- ----------------------------------------------------------
(b) LEI: NA
----- ----------------------------------------------------------
4. Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
----- ----------------------------------------------------------
(a) Description of the Financial instrument, type
of instrument: Rex Bionics Option over Ordinary
Shares of 10p each
Identification code: ISIN: GB00BLRLQM66
----- ----------------------------------------------------------
(b) Nature of the transaction: Issue of awards
under Deferred Bonus Share Plan
----- ----------------------------------------------------------
(c) Price(s) and volume(s)
Price(s): 10p per Ordinary Share
Volume(s): 134,070
----- ----------------------------------------------------------
(d) Aggregated information
* Aggregated volume: 134,070 Ordinary Shares awarded
* Price: Exercise price: 10p per Ordinary Share
----- ----------------------------------------------------------
(e) Date of the transaction: 27 September 2016
----- ----------------------------------------------------------
(f) Place of the transaction: London Stock Exchange
- AIM
----- ----------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFELATIDFIR
(END) Dow Jones Newswires
September 27, 2016 08:00 ET (12:00 GMT)
Rex Bionics (LSE:RXB)
Historical Stock Chart
From Oct 2024 to Nov 2024
Rex Bionics (LSE:RXB)
Historical Stock Chart
From Nov 2023 to Nov 2024
